Tradestie Institutional Equity Comparison Engine
VOR vs WVE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VOR Overall Edge
VOR Captures Institutional Edge (4โ0 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vor Biopharma Inc. Common Stock (VOR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VOR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus WVE at N/M Forward P/E and -320.9% operating margin (+73.0% YoY). In options structure, VOR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against WVE sits in BREAKDOWN (48th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
VOR
VOR N/M vs WVE N/M Fwd P/E
Growth & Margin Winner
VOR
Op Margin 0.0% vs -320.9% ยท YoY +0.0% vs +73.0%
Momentum & Technical Winner
VOR
1Y +94.6% vs -57.0% ยท 52W Pos 64% vs 0%
Options & Structure Winner
VOR
CONSOLIDATION (6th %ile IV) vs BREAKDOWN (48th %ile IV)
VOR
NASDAQ
Vor Biopharma Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$18.97
-2.32% 1D
Market Cap
$1.2B
1M Return
+5.21%
1Y Return
+94.56%
Forward P/E
N/M
Unified AI Score
57.8 / 100
HOLD
Tech 50.0
Fund 55.0
Flow 66.0
Mom 50.0
WVE
NASDAQ
Wave Life Sciences Ltd. Ordinary Shares
Pharmaceutical Preparations
$2.87
-8.31% 1D
Market Cap
$617.3M
1M Return
-8.31%
1Y Return
-56.97%
Forward P/E
N/M
Unified AI Score
41.5 / 100
SELL
Tech 21.0
Fund 46.0
Flow 68.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VOR +94.56%
WVE -56.97%
Spread: +151.53 pp (VOR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
VOR TTM Op. Margin: 0.0%
WVE TTM Op. Margin: -320.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VOR vs WVE. Trailing 12-month operating profitability (VOR 0.0% vs WVE -320.9%) and valuation multiples (VOR N/M vs WVE N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VOR | WVE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $617.3M | Larger Scale | VOR |
| Trailing P/E Ratio Valuation | 0.1x | N/M | Lower Multiple | VOR |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +73.0% | Higher Growth | WVE |
| Operating Margin (TTM) Profitability | 0.0% | -320.9% | Higher Margin | VOR |
| Net Profit Margin Profitability | 0.0% | -296.9% | Higher Margin | VOR |
| Return on Equity (ROE) Capital Efficiency | -125.4% | -78.8% | Higher ROE | WVE |
| 52-Week Range Position Momentum | 64% ($6โ$26) | 0% ($3โ$21) | Stronger Trend | VOR |
| Beta / 30D Volatility Risk Regime | 1.90ฮฒ ยท 61% Vol | 1.94ฮฒ ยท 76% Vol | Lower Realized Risk | VOR |
| Unified Institutional Score Composite Signal | 57.8 / 100 (HOLD) | 41.5 / 100 (SELL) | Higher Composite | VOR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VOR vs WVE Buy Guide
VOR
CONSOLIDATION
52d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
6th %ile
IV Regime
Compressed (<25th %ile)
WVE
BREAKDOWN
149d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
48th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VOR nor WVE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.